论文信息 - Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma - 字舞流文

Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma

S. Lyons | Sania Jevtic | R. Sordella | Polona Safaric Tepes | Danilo Segovia | Daniel Ramirez | Raffaella Sordella | Danilo Segovia